Livzon Pharmaceutical updates on share buyback activities

Livzon Pharmaceutical Group Inc. submitted its Next Day Disclosure Return on September 5, 2025, detailing changes in its A and H ordinary shares. For H ordinary shares (stock code 01513), the closing balance as of September 5, 2025, remained at 299,807,117. There were no changes in issued H shares or treasury H shares reported on this date.

The company also disclosed extensive A share repurchase activities. As of September 5, 2025, the total number of A shares repurchased for cancellation but not yet cancelled stood at 604,293,313. On September 5, 2025, Livzon repurchased 72,990 A shares on another stock exchange, with a volume-weighted average price of RMB 41.7 per share and a lowest price of RMB 40.51 per share, totaling RMB 2,999,471.1.

This recent repurchase activity on September 5, 2025, follows a series of A share buybacks conducted between December 2024 and August 2025, with individual transaction values ranging from RMB 34.00 to RMB 41.99 per share. These repurchased shares are yet to be cancelled, maintaining the stated closing balance.